Abstract

Staphylococcus aureus (SA) leukocidin LukED belongs to a family of bicomponent pore forming toxins that play important roles in SA immune evasion and nutrient acquisition. LukED targets specific G protein-coupled chemokine receptors to lyse human erythrocytes (red blood cells) and leukocytes (white blood cells). The first recognition step of receptors is critical for specific cell targeting and lysis. The structural and molecular bases for this mechanism are not well understood but could constitute essential information to guide antibiotic development. Here, we characterized the interaction of LukE with chemokine receptors ACKR1, CCR2 and CCR5 using a combination of structural, pharmacological and computational approaches. First, crystal structures of LukE in complex with a small molecule mimicking sulfotyrosine side chain (p-cresyl sulfate) and with peptides containing sulfotyrosines issued from receptor sequences revealed the location of receptor sulfotyrosine binding sites in the toxins. Then, by combining previous and novel experimental data with protein docking, classical and accelerated weight histogram (AWH) molecular dynamics we propose models of the ACKR1-LukE and CCR5-LukE complexes. This work provides novel insights into chemokine receptor recognition by leukotoxins and suggests that the conserved sulfotyrosine binding pocket could be a target of choice for future drug development.

Data availability

Diffraction data have been deposited in PDB under the accession codes 7P8T, 7P8S, 7P8U, 7P8X and 7P93. Source Data files containing the computational models of the ACKR1-LukE and CCR5-LukE complexes in Figures 6 and 7 have been provided as pdb files. Figure 2 - Source Data 1 contain the numerical data used to generate the figure.

Article and author information

Author details

  1. Paul Lambey

    Institut de Génomique Fonctionnelle, CNRS, INSERM, Université de Montpellier, Montpellier, France
    Competing interests
    The authors declare that no competing interests exist.
  2. Omolade Otun

    Institut de Génomique Fonctionnelle, CNRS, INSERM, Université de Montpellier, Montpellier, France
    Competing interests
    The authors declare that no competing interests exist.
  3. Xiaojing Cong

    Institut de Génomique Fonctionnelle, CNRS, INSERM, Université de Montpellier, Montpellier, France
    Competing interests
    The authors declare that no competing interests exist.
  4. François Hoh

    Centre de Biochimie Structurale, CNRS UMR 5048-INSERM 1054- University of Montpellier, Montpellier, France
    Competing interests
    The authors declare that no competing interests exist.
  5. Luc Brunel

    Centre de Biochimie Structurale, CNRS UMR 5048-INSERM 1054- University of Montpellier, Montpellier, France
    Competing interests
    The authors declare that no competing interests exist.
  6. Pascal Verdié

    Centre de Biochimie Structurale, CNRS UMR 5048-INSERM 1054- University of Montpellier, Montpellier, France
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5807-0293
  7. Claire M Grison

    Institut de Génomique Fonctionnelle, CNRS, INSERM, Université de Montpellier, Montpellier, France
    Competing interests
    The authors declare that no competing interests exist.
  8. Fanny Peysson

    Institut de Génomique Fonctionnelle, CNRS, INSERM, Université de Montpellier, Montpellier, France
    Competing interests
    The authors declare that no competing interests exist.
  9. Sylvain Jeannot

    Institut de Génomique Fonctionnelle, CNRS, INSERM, Université de Montpellier, Montpellier, France
    Competing interests
    The authors declare that no competing interests exist.
  10. Thierry Durroux

    Institut de Génomique Fonctionnelle, CNRS, INSERM, Université de Montpellier, Montpellier, France
    Competing interests
    The authors declare that no competing interests exist.
  11. Cherine Betara

    Institut de Génomique Fonctionnelle, CNRS, INSERM, Université de Montpellier, Montpellier, France
    Competing interests
    The authors declare that no competing interests exist.
  12. Sébastien Granier

    Institut de Génomique Fonctionnelle, CNRS, INSERM, Université de Montpellier, Montpellier, France
    For correspondence
    sebastien.granier@igf.cnrs.fr
    Competing interests
    The authors declare that no competing interests exist.
  13. Cédric Leyrat

    Institut de Génomique Fonctionnelle, CNRS, INSERM, Université de Montpellier, Montpellier, France
    For correspondence
    cedric.leyrat@igf.cnrs.fr
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0189-0562

Funding

Agence Nationale de la Recherche (ANR-17-CE15-0002-01)

  • Cédric Leyrat

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2022, Lambey et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,385
    views
  • 230
    downloads
  • 6
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Paul Lambey
  2. Omolade Otun
  3. Xiaojing Cong
  4. François Hoh
  5. Luc Brunel
  6. Pascal Verdié
  7. Claire M Grison
  8. Fanny Peysson
  9. Sylvain Jeannot
  10. Thierry Durroux
  11. Cherine Betara
  12. Sébastien Granier
  13. Cédric Leyrat
(2022)
Structural insights into recognition of chemokine receptors by Staphylococcus aureus leukotoxins
eLife 11:e72555.
https://doi.org/10.7554/eLife.72555

Share this article

https://doi.org/10.7554/eLife.72555

Further reading

    1. Immunology and Inflammation
    2. Microbiology and Infectious Disease
    Benita Martin-Castaño, Patricia Diez-Echave ... Julio Galvez
    Research Article

    Coronavirus disease 2019 (COVID-19) is a respiratory illness caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that displays great variability in clinical phenotype. Many factors have been described to be correlated with its severity, and microbiota could play a key role in the infection, progression, and outcome of the disease. SARS-CoV-2 infection has been associated with nasopharyngeal and gut dysbiosis and higher abundance of opportunistic pathogens. To identify new prognostic markers for the disease, a multicentre prospective observational cohort study was carried out in COVID-19 patients divided into three cohorts based on symptomatology: mild (n = 24), moderate (n = 51), and severe/critical (n = 31). Faecal and nasopharyngeal samples were taken, and the microbiota was analysed. Linear discriminant analysis identified Mycoplasma salivarium, Prevotella dentalis, and Haemophilus parainfluenzae as biomarkers of severe COVID-19 in nasopharyngeal microbiota, while Prevotella bivia and Prevotella timonensis were defined in faecal microbiota. Additionally, a connection between faecal and nasopharyngeal microbiota was identified, with a significant ratio between P. timonensis (faeces) and P. dentalis and M. salivarium (nasopharyngeal) abundances found in critically ill patients. This ratio could serve as a novel prognostic tool for identifying severe COVID-19 cases.

    1. Microbiology and Infectious Disease
    Vivian C Salgueiro-Toledo, Jorge Bertol ... Rafael Prados-Rosales
    Research Article

    Pathogenic and nonpathogenic mycobacteria secrete extracellular vesicles (EVs) under various conditions. EVs produced by Mycobacterium tuberculosis (Mtb) have raised significant interest for their potential in cell communication, nutrient acquisition, and immune evasion. However, the relevance of vesicle secretion during tuberculosis infection remains unknown due to the limited understanding of mycobacterial vesicle biogenesis. We have previously shown that a transposon mutant in the LCP-related gene virR (virRmut) manifested a strong attenuated phenotype during experimental macrophage and murine infections, concomitant to enhanced vesicle release. In this study, we aimed to understand the role of VirR in the vesicle production process in Mtb. We employ genetic, transcriptional, proteomics, ultrastructural, and biochemical methods to investigate the underlying processes explaining the enhanced vesiculogenesis phenomenon observed in the virRmut. Our results establish that VirR is critical to sustain proper cell permeability via regulation of cell envelope remodeling possibly through the interaction with similar cell envelope proteins, which control the link between peptidoglycan and arabinogalactan. These findings advance our understanding of mycobacterial extracellular vesicle biogenesis and suggest that these set of proteins could be attractive targets for therapeutic intervention.